Zynerba Pharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Zynerba Pharmaceuticals, Inc.
CIK #0001621443
EDGAR Form CIK 2011 - 2024
10-K [0001621443]
10-Q [0001621443]
3 [0001621443]
4 [0001621443]
8-K [0001621443]
D [0001621443]
SC 13G [0001621443]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vanguard Group Inc Zynerba Pharmaceuticals Inc [2020-02-11]
BlackRock Inc Zynerba Pharmaceuticals Inc [2020-02-07]
ETF Managers Group LLC Zynerba Pharmaceuticals Inc [2019-06-04]
BlackRock Inc Zynerba Pharmaceuticals Inc [2018-02-01]
Cormorant Global Healthcare Master Fund LP Zynerba Pharmaceuticals Inc [2016-03-04]
Rapp Michael Zynerba Pharmaceuticals Inc [2016-02-16]
RA Capital Management LLC Zynerba Pharmaceuticals Inc [2015-10-14]
Benovitz Ethan Zynerba Pharmaceuticals Inc [2015-08-14]
Form 3/4/5 Subject 2011 - 2024
Zynerba Pharmaceuticals, Inc.
Parker Albert P
Anido Armando
Sebree Terri B
Fickenscher James E
Rosenberger Brian
Federici William J
Kisner Daniel L
Butler John P.
Cooper Warren D
View All
Terms | Privacy | Guide
tony@aum13f.com